Remove 2022 Remove BioTech Remove Digital Health Remove Leadership
article thumbnail

BioscienceLA Launches Leadership Catalyst Program For Emerging Leaders in the Life Sciences

Digital Health Global

–(BUSINESS WIRE)– #Biotech –Taking a people-first approach, BioscienceLA, the ecosystem accelerator for life sciences in Greater Los Angeles, has launched its inaugural Leadership Catalyst Program for trailblazers in biotechnology and related sectors.

article thumbnail

Turbine Upsizes its Series A Round to €25.5 Million and Appoints Seasoned Independent Directors to its Board

Digital Health Global

Earlier in his career, Mr. Kamkolkar served in enterprise data science, digital & AI leadership roles at Sanofi and Novartis. Dr. Rhodes brings more than 25 years of drug discovery, company building and strategic leadership in the biotech industry, including 18 years at Biogen. Jane Rhodes, Ph.D., Jane Rhodes, Ph.D.,

BioTech 88
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Scotland's Pioneering Spirit: A Legacy of Medical and Healthcare Innovation

Lloyd Price

Exec Summary: Scotland has emerged as a global leader in the field of digital health and care, driven by a combination of factors: A strong foundation in medical innovation: Scotland boasts a rich history of medical breakthroughs, from the world's first cloned sheep (Dolly) to pioneering research in stem cell therapy.

article thumbnail

Aptar Appoints Julie Xing to its Board of Directors

Digital Health Global

With over 20 years of experience in pharmaceutical, medtech, digital health, biotech and diagnosis, Julie’s leadership approach focuses on inspiring teams to deliver sustainable growth in challenging markets and healthcare environments. Mundipharma is a global pharmaceutical leader. Tanda, Aptar President and CEO.

article thumbnail

Third Culture Capital Leads Latest Funding Round for Ciba Health

Digital Health Global

Clement and his team will gather even greater interest and business engagement for Ciba Health after this financing round.” 3CC’s support reinforces Ciba Health’s values of advancing equity, diversity and inclusion in healthcare delivery, and improving care delivery through innovative and global technology solutions.

article thumbnail

Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to Advent International and Warburg Pincus for $4.25 Billion

Digital Health Global

“BPS has long been recognized worldwide as a trusted and preferred partner of contract manufacturing services for the pharmaceutical and biotech industries. BPS has been a leading provider of sterile contract manufacturing solutions, parenteral delivery systems and customized support services to the pharma and biotech industries for decades.